# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001493152-24-009580
Filing Date
2024-03-11
Accepted
2024-03-11 16:30:08
Documents
4
Period of Report
2024-03-11

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | formpre14a.htm | PRE 14A | 661355
2 |  | formpre14a_001.jpg | GRAPHIC | 5591
3 |  | proxy_001.jpg | GRAPHIC | 460465
4 |  | proxy_002.jpg | GRAPHIC | 67201
| Complete submission text file | 0001493152-24-009580.txt |  | 1397191

Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Tharimmune, Inc. (Filer) CIK: 0001861657 (see all company filings)

EIN.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-41210 | Film No.: 24738444
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)